Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ReproCELL Inc

+ Add to Watchlist


678.0 JPY 1.0 0.15%

As of 02:00:00 ET on 04/24/2015.

Company Profile for ReproCELL Inc (4978)

ReproCell Incorporated develops iPS (Induced Pluripotent Stem Cell) business and clinical examination for organ transplantation based on human iPS and ES (Embryonic Stem Cell) technology.

Contact Information

ReproCELL Inc

3-8-11 Shin Yokohama
Kouhoku-ku, Kanakawa
Yokohama, 222-0033
Phone: 81-45-475-3887

Key Executives for ReproCELL Inc (4978)

Chikafumi YokoyamaPresidentHiromi KatayamaDirector
Takashi MasaiDirector

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil